3836 Quakerbridge Road
Hamilton, NJ 08619
Fran Gallagher, MEd
Associate Director of Programs
Steven Kairys, MD, MPH, FAAP
Chair / Medical Director
Jeanne Craft, MD, FAAP
Michael Segarra, MD, FAAP
Dahlia Hall, MD, MPH, FAAP
Mary Jo Garofoli
Phone - 609-588-9988
Fax - 609-588-9901
Funded by New Jersey Department of Health and Senior Services, Vaccine Preventable Disease Program
(ECI) Early Childhood Immunization
Immunization Initiative 2012
The goal of the Immunization Initiative program is to support efforts to have at least 90.0 percent of New Jersey’s children (from birth through 18 yrs.) timely and appropriately immunized against all recommended vaccine preventable diseases. To assist in achieving this goal, our first objective will focus on gaining insights and data on current immunizations status and increasing the awareness of primary health care providers about the importance of age appropriate childhood immunizations, identifying barriers and challenges to providing immunizations and defining and implementing strategies and best practices for improving immunization service delivery.
The Immunization Initiative program is designed to work with both primary care practices and child care centers to raise awareness of the importance of age appropriate childhood immunizations.
- Orientation meetings to outline the role of the Immunization Initiative program for interested primary care practices and child care centers
- Establish and assess/reassess immunization status for a primary care practice’s two-year old and thirteen yr. old patient population
- Provide educational sessions, materials, and resources on topics including vaccine preventable diseases, immunization requirements and the NJ Immunization Information System (NJIIS).
Offer Practice Innovator meetings for participating practices to attend and obtain feedback on their immunization status, based on their own data, and to learn about and share strategies to improve practice
If you are a primary care provider or a child care provider and would like to participate in this program, please contact Judith Grandjean, Co-Director at email@example.com or phone 609-588-9988.
Do You Really Know the Up-to-Date Immunization Status of Your Adolescent Patients? PCORE’s Immunization Initiative team can assist and support practices who are interested in assessing and understanding their adolescent (13 yr. old) immunization rates. This valuable information can help your practice team evaluate your current well-care policies for this patient population.
By following the easy data collection protocol, you will receive FREE site-specific reports, as well as feedback on strategies and opportunities to improve immunization coverage rates.
We hope you will take advantage of this opportunity for your team to get a “snapshot” of the adolescent immunization rates in your practice! Please contact Program Co-Director, Judie Grandjean at firstname.lastname@example.org for more information.
Since mid-2011, a substantial rise in pertussis cases has been reported in the state of Washington. In response to this increase, the Washington State Secretary of Health declared a pertussis epidemic on April 3, 2012. By June 16, the reported number of cases in Washington in 2012 had reached 2,520 (37.5 cases per 100,000 residents), a 1,300% increase compared with the same period in 2011 and the highest number of cases reported in any year since 1942. To assess clinical, epidemiologic, and laboratory factors associated with this increase, all pertussis cases reported during January 1–June 16, 2012, were reviewed. Consistent with national trends, high rates of pertussis were observed among infants aged <1 year and children aged 10 years. However, the incidence in adolescents aged 13–14 years also was increased, despite high rates of vaccination with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine, suggesting early waning of immunity. The focus of prevention and control efforts is the protection of infants and others at greatest risk for severe disease and improving vaccination coverage in adolescents and adults, especially those who are pregnant. Pertussis vaccination remains the single most effective strategy for prevention of infection. Read more...
Whooping cough cases on rise, New York urges vaccinations
New York health officials on Wednesday reported a sharp spike in cases of whooping cough, a potentially fatal illness that has been on the rise around the country this year, and urged people to get vaccinated. Read more...
Ten Great Public Health Achievements --- United States, 2001--2010
During the 20th century, life expectancy at birth among U.S. residents increased by 62%, from 47.3 years in 1900 to 76.8 in 2000, and unprecedented improvements in population health status were observed at every stage of life (1). In 1999, MMWR published a series of reports highlighting 10 public health achievements that contributed to those improvements. This report assesses advances in public health during the first 10 years of the 21st century. Public health scientists at CDC were asked to nominate noteworthy public health achievements that occurred in the United States during 2001--2010. From those nominations, 10 achievements, not ranked in any order, have been summarized in this report.
Prevention and Conftrol of Infectious Disease
Mental and Infant Health
Motor Vehicle Safety
Cardiovascular Disease Prevention
Childhood Lead Poisoning Prevention
Public Health Preparedness and Response
Measles cases reported in the U.S. are at highest level since 1996
Measles cases so far this year are at their highest level since 1996, prompting federal health authorities to urge that children be vaccinated earlier.
Of the 118 cases reported through Friday in the U.S., 105 were associated with importation from other countries, the federal Centers for Disease Control and Prevention said in a report issued Tuesday. The greatest numbers came from Europe and Southeast Asia.
Though 40 percent of the American cases have required hospitalization, none resulted in encephalitis or death.
read more ...
Meningococcal Vaccine Approved for Infants and Toddlers
The FDA has approved use of the meningococcal vaccine Menactra in children as young as age 9 months.
The vaccine had already been approved for use in children 2 years and older. In announcing its action on Friday, the agency noted that the highest rates of meningococcal disease occur in children under 1 year of age. With the new approval, the vaccine can be given in two doses, 3 months apart.